Academic Journals Database
Disseminating quality controlled scientific knowledge

Ramipril in therapy of patients after myocardial infarction

ADD TO MY LIST
 
Author(s): V. Szirov | E. V. Malichenko

Journal: Racionalʹnaâ Farmakoterapiâ v Kardiologii
ISSN 1819-6446

Volume: 3;
Issue: 4;
Start page: 58;
Date: 2007;
Original page

Keywords: acute myocardial infarction | angiotensin converting enzyme | ramipril

ABSTRACT
Angiotensin converting enzyme inhibitors are the first line medicine for the treatment of the most of cardiovascular diseases. There is no class-effect for these drugs in myocardial infarction therapy. Moreover in myocardial infarction angiotensin converting enzyme inhibitors have significant intra-group differences. Ramipril is the one of the most studied drug of this group recommended for patients after acute myocardial infarction.
Why do you need a reservation system?      Save time & money - Smart Internet Solutions